Privia Health Group, Inc. Selling and Marketing Expense
Privia Health Group, Inc. (PRVA) reported Selling and Marketing Expense of $8.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-06
- Privia Health Group, Inc. selling and marketing expense for the quarter ending 2026-06-30 was $8.00M, a 17.59% increase year-over-year.
- Privia Health Group, Inc. selling and marketing expense for the quarter ending 2026-03-31 was $8.13M, a 17.51% increase year-over-year.
- Privia Health Group, Inc. selling and marketing expense for the quarter ending 2025-12-31 was $6.45M, a 0.20% decline year-over-year.
- Privia Health Group, Inc. selling and marketing expense for the quarter ending 2025-09-30 was $6.96M, a 1.23% decline year-over-year.
- Privia Health Group, Inc. selling and marketing expense for fiscal 2025 was $27.14M, a 2.61% increase from fiscal 2024.
- Privia Health Group, Inc. selling and marketing expense for fiscal 2024 was $26.45M, a 6.93% increase from fiscal 2023.
- Privia Health Group, Inc. selling and marketing expense for fiscal 2023 was $24.73M, a 25.28% increase from fiscal 2022.
- Privia Health Group, Inc. selling and marketing expense for fiscal 2022 was $19.74M, a 13.23% decline from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.00M 10-Q · filed 2026-08-06 | $16.14M 10-Q · filed 2026-08-06 | $22.59M derived: sum of 3 quarters · filed 2026-08-06 | $29.55M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $8.13M 10-Q · filed 2026-05-07 | $14.58M derived: sum of 2 quarters · filed 2026-05-07 | $21.54M derived: sum of 3 quarters · filed 2026-05-07 | $28.35M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $6.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $13.41M derived: sum of 2 quarters · filed 2026-02-27 | $20.21M derived: sum of 3 quarters · filed 2026-08-06 | $27.14M 10-K · filed 2026-02-27 |
| 2025-09-30 | $6.96M 10-Q · filed 2025-11-06 | $13.77M derived: sum of 2 quarters · filed 2026-08-06 | $20.69M 10-Q · filed 2025-11-06 | $27.15M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $6.80M 10-Q · filed 2026-08-06 | $13.73M 10-Q · filed 2026-08-06 | $20.19M derived: sum of 3 quarters · filed 2026-08-06 | $27.24M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $6.92M 10-Q · filed 2026-05-07 | $13.38M derived: sum of 2 quarters · filed 2026-05-07 | $20.43M derived: sum of 3 quarters · filed 2026-05-07 | $27.28M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $6.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $13.51M derived: sum of 2 quarters · filed 2026-02-27 | $20.36M derived: sum of 3 quarters · filed 2026-02-27 | $26.45M 10-K · filed 2026-02-27 |
| 2024-09-30 | $7.05M 10-Q · filed 2025-11-06 | $13.90M derived: sum of 2 quarters · filed 2025-11-06 | $19.98M 10-Q · filed 2025-11-06 | $26.23M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $6.85M 10-Q · filed 2025-08-07 | $12.94M 10-Q · filed 2025-08-07 | $19.19M derived: sum of 3 quarters · filed 2026-02-27 | $26.43M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $6.08M 10-Q · filed 2025-05-08 | $12.33M derived: sum of 2 quarters · filed 2026-02-27 | $19.57M derived: sum of 3 quarters · filed 2026-02-27 | $25.53M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $6.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $13.49M derived: sum of 2 quarters · filed 2026-02-27 | $19.45M derived: sum of 3 quarters · filed 2026-02-27 | $24.73M 10-K · filed 2026-02-27 |
| 2023-09-30 | $7.24M 10-Q · filed 2024-11-07 | $13.20M derived: sum of 2 quarters · filed 2024-11-07 | $18.48M 10-Q · filed 2024-11-07 | $23.66M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $5.96M 10-Q · filed 2024-08-08 | $11.24M 10-Q · filed 2024-08-08 | $16.41M derived: sum of 3 quarters · filed 2025-02-27 | $21.50M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $5.29M 10-Q · filed 2024-05-09 | $10.46M derived: sum of 2 quarters · filed 2025-02-27 | $15.55M derived: sum of 3 quarters · filed 2025-02-27 | $20.37M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $5.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $10.26M derived: sum of 2 quarters · filed 2025-02-27 | $15.08M derived: sum of 3 quarters · filed 2025-02-27 | $19.74M 10-K · filed 2025-02-27 |
| 2022-09-30 | $5.09M 10-Q · filed 2023-11-03 | $9.91M derived: sum of 2 quarters · filed 2023-11-03 | $14.57M 10-Q · filed 2023-11-03 | $18.37M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $4.82M 10-Q · filed 2023-08-03 | $9.48M 10-Q · filed 2023-08-03 | $13.28M derived: sum of 3 quarters · filed 2024-02-27 | $17.87M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $4.66M 10-Q · filed 2023-05-04 | $8.46M derived: sum of 2 quarters · filed 2024-02-27 | $13.05M derived: sum of 3 quarters · filed 2024-02-27 | $24.23M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $8.39M derived: sum of 2 quarters · filed 2024-02-27 | $19.57M derived: sum of 3 quarters · filed 2024-02-27 | $22.75M 10-K · filed 2024-02-27 |
| 2021-09-30 | $4.59M 10-Q · filed 2022-11-10 | $15.77M derived: sum of 2 quarters · filed 2022-11-10 | $18.95M 10-Q · filed 2022-11-10 | $22.91M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $11.18M 10-Q · filed 2022-08-11 | $14.36M 10-Q · filed 2022-08-11 | $18.32M derived: sum of 3 quarters · filed 2023-03-01 | $21.03M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $3.18M 10-Q · filed 2022-05-12 | $7.15M derived: sum of 2 quarters · filed 2023-03-01 | $9.86M derived: sum of 3 quarters · filed 2023-03-01 | $12.07M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $6.67M derived: sum of 2 quarters · filed 2023-03-01 | $8.89M derived: sum of 3 quarters · filed 2023-03-01 | $11.34M 10-K · filed 2023-03-01 |
| 2020-09-30 | $2.71M 10-Q · filed 2021-11-08 | $4.93M derived: sum of 2 quarters · filed 2021-11-08 | $7.38M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $2.22M 10-Q · filed 2021-08-09 | $4.67M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $2.45M 10-Q · filed 2021-05-28 | |||
| 2019-12-31 | $9.16M 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |